New high-cost HIV prevention drug: 'Better' isn't worth it - Virology Hub

New high-cost HIV prevention drug: ‘Better’ isn’t worth it



A newly approved drug for HIV pre-exposure prophylaxis (PrEP) is unlikely to confer any discernible health benefit over generic alternatives and may undermine efforts to expand access to HIV prevention for the nation’s most vulnerable populations, according to a new study appearing today in the Annals of Internal Medicine.



Source link

We will be happy to hear your thoughts

Leave a reply

Virology Hub
Logo
Enable registration in settings - general
%d bloggers like this: